Value, development challenges, and strategies for gaining internal endorsement of digitally connected subcutaneous drug delivery devices: a survey of pharmaceutical stakeholders.
Saved in:
| Title: | Value, development challenges, and strategies for gaining internal endorsement of digitally connected subcutaneous drug delivery devices: a survey of pharmaceutical stakeholders. |
|---|---|
| Authors: | Swick A; Enable Injections, Inc., Cincinnati, OH, United States., Peri SP; Eli Lilly and Company, Indianapolis, IN, United States., Hill T; Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel., Datoo M; Johnson & Johnson, New Brunswick, NJ, United States., Morra D; Merck & Co., Inc., Rahway, NJ, United States., Desai M; Enable Injections, Inc., Cincinnati, OH, United States., Rahman O; Enable Injections, Inc., Cincinnati, OH, United States. |
| Source: | Frontiers in digital health [Front Digit Health] 2026 Mar 26; Vol. 8, pp. 1684685. Date of Electronic Publication: 2026 Mar 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101771889 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-253X (Electronic) Linking ISSN: 2673253X NLM ISO Abbreviation: Front Digit Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2673-253X |
|---|---|
| DOI: | 10.3389/fdgth.2026.1684685 |
